US biotech Dewpoint Therapeutics has announced that the US Food and Drug Administration (FDA) has granted Fast Track ...

The US-China Economic and Security Review Commission has presented its 2025 annual report to Congress in the USA.

Merck & Co, known as MSD outside of the USA and Canada, today announced that the European Commission (EC) has approved a new ...

Cambridge, USA-based mRNA vaccines company Moderna today announced the expansion of its US manufacturing capabilities with ...

A new industry-supported study released for World AMR Awareness Week highlights widening gaps between falling antibiotic ...

Specialty pharma company SERB Pharmaceuticals has revealed the appointment of Vignesh Rajah as its chief medical officer (CMO ...

Xiangxue Life Sciences has agreed a strategic partnership with Guangzhou-based Damien Vaccines to co-develop in vivo TCR-T ...

US pharma major Merck (NYSE: MRK) has reported positive topline data from the Phase II Cadence trial, testing Winrevair ...

The landscape of phosphodiesterase 3/4 (PDE3/4) inhibitors is experiencing a significant transformation in 2025, driven by ...

The US Food and Drug Administration (FDA) published the final guidance for industry, “Considerations for Waiver Requests for ...

The European Commission has granted conditional marketing authorization of Roche’s Lunsumio (mosunetuzumab) subcutaneous (SC) ...

US RNA interference (RNAi)specialist Arrowhead Pharmaceuticals, yesterday revealed that the US Food and Drug Administration ...